The number of γδT cells was negatively associated with the progression of CC [89]. γδT cells alone were found to inhibit tumour growth, and if combined with galectin-1 antibody, they could provide a more effective immunotherapy for CC [90]. The gene discussed is LGALS1; the disease is cholangiocarcinoma.